Brain-derived Neurotrophic Factor Levels in Late-life Depression and Comorbid Mild Cognitive Impairment: a Longitudinal Study

Overview

Journal J Psychiatr Res

Specialty Psychiatry

Date 2013 Dec 3

PMID 24290367

Citations 31

Authors

Breno Satler Diniz

Charles F Reynolds 3rd

Amy Begley

Mary Amanda Dew

Stewart J Anderson

Francis Lotrich

Kirk I Erickson

Oscar Lopez

Howard Aizenstein

Etienne L Sibille

Meryl A Butters

Affiliations

Soon will be listed here.

Abstract

Changes in brain-derived neurotrophic factor (BDNF) level are implicated in the pathophysiology of cognitive decline in depression and neurodegenerative disorders in older adults. We aimed to evaluate the longitudinal association over two years between BDNF and persistent cognitive decline in individuals with remitted late-life depression and Mild Cognitive Impairment (LLD + MCI) compared to either individuals with remitted LLD and no cognitive decline (LLD + NCD) or never-depressed, cognitively normal, elderly control participants. We additionally evaluated the effect of double-blind, placebo-controlled donepezil treatment on BDNF levels in all of the remitted LLD participants (across the levels of cognitive function). We included 160 elderly participants in this study (72 LLD + NCD, 55 LLD + MCI and 33 never-depressed cognitively normal elderly participants). At the same visits, cognitive assessments were conducted and blood sampling to determine serum BDNF levels were collected at baseline assessment and after one and two years of follow-up. We utilized repeated measure, mixed effect models to assess: (1) the effects of diagnosis (LLD + MCI, LLD + NCD, and controls), time, and their interaction on BDNF levels; and (2) the effects of donepezil treatment (donepezil vs. placebo), time, baseline diagnosis (LLD + MCI vs. LLD + NCD), and interactions between these contrasts on BDNF levels. We found a significant effect of time on BDNF level (p = 0.02) and a significant decline in BDNF levels over 2 years of follow-up in participants with LLD + MCI (p = 0.004) and controls (p = 0.04). We found no effect of donepezil treatment on BDNF level. The present results suggest that aging is an important factor related to decline in BDNF level. Clinicaltrials.gov Identifier: NCT00177671.

Citing Articles

Polyphenols' Impact on Selected Biomarkers of Brain Aging in Healthy Middle-Aged and Elderly Subjects: A Review of Clinical Trials.

Ziegler T, Tsiountsioura M, Meixner-Goetz L, Cvirn G, Lamprecht M Nutrients. 2023; 15(17).

PMID: 37686802 PMC: 10490411. DOI: 10.3390/nu15173770.

Major depression and the biological hallmarks of aging.

Lorenzo E, Kuchel G, Kuo C, Moffitt T, Diniz B Ageing Res Rev. 2022; 83:101805.

PMID: 36410621 PMC: 9772222. DOI: 10.1016/j.arr.2022.101805.

Inflammatory Markers of Geriatric Depression Response to Tai Chi or Health Education Adjunct Interventions.

Siddarth P, Abikenari M, Grzenda A, Cappelletti M, Oughli H, Liu C Am J Geriatr Psychiatry. 2022; 31(1):22-32.

PMID: 36175271 PMC: 10865899. DOI: 10.1016/j.jagp.2022.08.004.

Effects of meditation and mind-body exercise on brain-derived neurotrophic factor: A literature review of human experimental studies.

You T, Ogawa E Sports Med Health Sci. 2022; 2(1):7-9.

PMID: 35783336 PMC: 9219319. DOI: 10.1016/j.smhs.2020.03.001.

Geriatric Depression and Cognitive Impairment-An Update.

Mukku S, Dahale A, Muniswamy N, Muliyala K, Sivakumar P, Varghese M Indian J Psychol Med. 2021; 43(4):286-293.

PMID: 34385720 PMC: 8327864. DOI: 10.1177/0253717620981556.

References

Taylor W, Zuchner S, McQuoid D, Payne M, MacFall J, Steffens D . The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry. 2008; 16(4):263-71. DOI: 10.1097/JGP.0b013e3181591c30. View

Diniz B, Butters M, Albert S, Dew M, Reynolds 3rd C . Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013; 202(5):329-35. PMC: 3640214. DOI: 10.1192/bjp.bp.112.118307. View

Butters M, Young J, Lopez O, Aizenstein H, Mulsant B, Reynolds 3rd C . Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008; 10(3):345-57. PMC: 2872078. View

Diniz B, Teixeira A, Talib L, Mendonca V, Gattaz W, Forlenza O . Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry. 2010; 11(3):550-5. DOI: 10.3109/15622970903544620. View

Murer M, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B . An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience. 1999; 88(4):1015-32. DOI: 10.1016/s0306-4522(98)00219-x. View

Diniz B, Nunes P, Yassuda M, Forlenza O . Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord. 2009; 27(3):224-31. DOI: 10.1159/000203346. View

Sen S, Duman R, Sanacora G . Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008; 64(6):527-32. PMC: 2597158. DOI: 10.1016/j.biopsych.2008.05.005. View

Lee J, Shin B, You Y, Kim J, Yoon S, Jeon D . Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia. Psychiatry Investig. 2010; 6(4):299-305. PMC: 2808800. DOI: 10.4306/pi.2009.6.4.299. View

Forlenza O, Diniz B, Teixeira A, Ojopi E, Talib L, Mendonca V . Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry. 2010; 11(6):774-80. DOI: 10.3109/15622971003797241. View

10.

Doody R, Geldmacher D, Gordon B, Perdomo C, Pratt R . Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol. 2001; 58(3):427-33. DOI: 10.1001/archneur.58.3.427. View

11.

Teixeira A, Barbosa I, Diniz B, Kummer A . Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med. 2010; 4(6):871-87. DOI: 10.2217/bmm.10.111. View

12.

Douillard-Guilloux G, Guilloux J, Lewis D, Sibille E . Anticipated brain molecular aging in major depression. Am J Geriatr Psychiatry. 2013; 21(5):450-60. PMC: 3615087. DOI: 10.1016/j.jagp.2013.01.040. View

13.

Caraci F, Copani A, Nicoletti F, Drago F . Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol. 2009; 626(1):64-71. DOI: 10.1016/j.ejphar.2009.10.022. View

14.

Reynolds 3rd C, Butters M, Lopez O, Pollock B, Dew M, Mulsant B . Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry. 2011; 68(1):51-60. PMC: 3076045. DOI: 10.1001/archgenpsychiatry.2010.184. View

15.

Diniz B, Teixeira A . Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med. 2011; 13(4):217-22. DOI: 10.1007/s12017-011-8154-x. View

16.

Autio H, Matlik K, Rantamaki T, Lindemann L, Hoener M, Chao M . Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology. 2011; 61(8):1291-6. PMC: 3928503. DOI: 10.1016/j.neuropharm.2011.07.033. View

17.

Leyhe T, Stransky E, Eschweiler G, Buchkremer G, Laske C . Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2007; 258(2):124-8. DOI: 10.1007/s00406-007-0764-9. View

18.

Lu P, Edland S, Teng E, Tingus K, Petersen R, Cummings J . Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009; 72(24):2115-21. PMC: 2697965. DOI: 10.1212/WNL.0b013e3181aa52d3. View

19.

Petersen R, Thomas R, Grundman M, Bennett D, Doody R, Ferris S . Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005; 352(23):2379-88. DOI: 10.1056/NEJMoa050151. View

20.

Bhalla R, Butters M, Becker J, Houck P, Snitz B, Lopez O . Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry. 2009; 17(4):308-16. PMC: 2782929. DOI: 10.1097/JGP.0b013e318190b8d8. View